These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2475778)

  • 41. Affinity of estrogens for human progesterone receptor A and B monomers and risk of breast cancer: a comparative molecular modeling study.
    Hasan TN; B LG; Masoodi TA; Shafi G; Alshatwi AA; Sivashanmugham P
    Adv Appl Bioinform Chem; 2011; 4():29-36. PubMed ID: 21918635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibodies as prognostic indicators of tumor progression in breast cancer.
    Colnaghi MI; Agresti R; Ménard S; Da Dalt MG; Cattoretti G; Andreola S; Di Fronzo G; Del Vecchio M; Verderio L; Cascinelli N
    Adv Exp Med Biol; 1988; 233():319-27. PubMed ID: 2464907
    [No Abstract]   [Full Text] [Related]  

  • 43. Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis.
    Thompson S; Cantwell BM; Cornell C; Turner GA
    Br J Cancer; 1991 Aug; 64(2):386-90. PubMed ID: 1892771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic Profiling of HDL in Newly Diagnosed Breast Cancer Based on Tumor Molecular Classification and Clinical Stage of Disease.
    Santana MFM; Sawada MIBAC; Junior DRS; Giacaglia MB; Reis M; Xavier J; Côrrea-Giannella ML; Soriano FG; Gebrim LH; Ronsein GE; Passarelli M
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular and molecular features related to exceptional therapy response and extreme long-term survival in glioblastoma.
    Decraene B; Vanmechelen M; Clement P; Daisne JF; Vanden Bempt I; Sciot R; Garg AD; Agostinis P; De Smet F; De Vleeschouwer S
    Cancer Med; 2023 May; 12(10):11107-11126. PubMed ID: 36776000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haptoglobin genotypes and malaria comorbidity in breast cancer and healthy Nigerian women.
    Dokunmu TM; Obi PO; Fatiregun OA; Rotimi OA; Agodirin SO; Rotimi SO
    Ann Afr Med; 2022; 21(3):231-236. PubMed ID: 36204908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative.
    Ballinger TJ; Djuric Z; Sardesai S; Hovey KM; Andrews CA; Brasky TM; Zhang JT; Rohan TE; Saquib N; Shadyab AH; Simon M; Wactawski-Wende J; Wallace R; Kato I
    Nutr Cancer; 2023; 75(1):265-275. PubMed ID: 35968582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HNF1A POU Domain Mutations Found in Japanese Liver Cancer Patients Cause Downregulation of
    Haque E; Teeli AS; Winiarczyk D; Taguchi M; Sakuraba S; Kono H; Leszczyński P; Pierzchała M; Taniguchi H
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting cancer metabolism in the era of precision oncology.
    Stine ZE; Schug ZT; Salvino JM; Dang CV
    Nat Rev Drug Discov; 2022 Feb; 21(2):141-162. PubMed ID: 34862480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase.
    Wang CJ; Li D; Danielson JA; Zhang EH; Dong Z; Miller KD; Li L; Zhang JT; Liu JY
    Cancer Lett; 2021 Jul; 509():1-12. PubMed ID: 33813001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel Six-Gene-Based Prognostic Model Predicts Survival and Clinical Risk Score for Gastric Cancer.
    Li J; Pu K; Li C; Wang Y; Zhou Y
    Front Genet; 2021; 12():615834. PubMed ID: 33692828
    [No Abstract]   [Full Text] [Related]  

  • 52. Maternal DNA Methylation During Pregnancy: a Review.
    Das J; Maitra A
    Reprod Sci; 2021 Oct; 28(10):2758-2769. PubMed ID: 33469876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early diagnosis of colorectal cancer via plasma proteomic analysis of CRC and advanced adenomatous polyp.
    Fayazfar S; Zali H; Arefi Oskouie A; Asadzadeh Aghdaei H; Rezaei Tavirani M; Nazemalhosseini Mojarad E
    Gastroenterol Hepatol Bed Bench; 2019; 12(4):328-339. PubMed ID: 31749922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
    Lu J; Cowperthwaite MC; Burnett MG; Shpak M
    PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered.
    Kinlaw WB; Baures PW; Lupien LE; Davis WL; Kuemmerle NB
    J Cell Physiol; 2016 Oct; 231(10):2128-41. PubMed ID: 26844415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Signalling mechanisms regulating phenotypic changes in breast cancer cells.
    Volinsky N; McCarthy CJ; von Kriegsheim A; Saban N; Okada-Hatakeyama M; Kolch W; Kholodenko BN
    Biosci Rep; 2015 Mar; 35(2):. PubMed ID: 25643809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.
    Swierczynski J; Hebanowska A; Sledzinski T
    World J Gastroenterol; 2014 Mar; 20(9):2279-303. PubMed ID: 24605027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces fatty acid synthesis via downregulation of sterol regulatory element binding protein-1 and activation of acetyl CoA carboxylase.
    Al-Zoubi M; Chipitsyna G; Saxena S; Sarosiek K; Gandhi A; Kang CY; Relles D; Andrelsendecki J; Hyslop T; Yeo CJ; Arafat HA
    J Gastrointest Surg; 2014 Feb; 18(2):257-68; discussion 268. PubMed ID: 24091913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting SREBP-1-driven lipid metabolism to treat cancer.
    Guo D; Bell EH; Mischel P; Chakravarti A
    Curr Pharm Des; 2014; 20(15):2619-26. PubMed ID: 23859617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production.
    Liu H; Wu X; Dong Z; Luo Z; Zhao Z; Xu Y; Zhang JT
    J Lipid Res; 2013 Mar; 54(3):776-785. PubMed ID: 23319743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.